The Smad3 expression analysis showed a positive trend in distant metastatic lesions (M1) as compared to non-metastatic cases (M0); however, the trend was statistically insignificant ( P = 0.07) (Fig. 3 H).
← all excerpts
Glucocorticoid inhibits lung cancer cells proliferation and migration by suppressing smad2/3 activation.
1
—
—